FTAIM Q1 2026 Earnings Preferred Dividend Coverage Tightens as EPS Misses Estimates by 15 MoonLake Immunotherapeutics MLTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline CVGI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment SSSSL Q1 2026 Earnings Massive EPS Surprise Driven by Investment Gains SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development OCCIN Q1 2026 Earnings Significant EPS Miss Amid Operating Challenges